Veradigm Inc (MDRX)
OTCMKTS: MDRX · Delayed Price · USD
7.70
-0.10 (-1.28%)
May 3, 2024, 3:54 PM EDT - Market closed
Veradigm Employees
Veradigm had 8,000 employees on December 31, 2021. The number of employees decreased by 400 or -4.76% compared to the previous year.
Employees
8,000
Change (1Y)
-400
Growth (1Y)
-4.76%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
828.83M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 8,000 | -400 | -4.76% |
Dec 31, 2020 | 8,400 | -1,200 | -12.50% |
Dec 31, 2019 | 9,600 | 100 | 1.05% |
Dec 31, 2018 | 9,500 | 600 | 6.74% |
Dec 31, 2017 | 8,900 | 1,400 | 18.67% |
Dec 31, 2016 | 7,500 | 600 | 8.70% |
Dec 31, 2015 | 6,900 | -300 | -4.17% |
Dec 31, 2014 | 7,200 | 0 | - |
Dec 31, 2013 | 7,200 | 100 | 1.41% |
Dec 31, 2012 | 7,100 | 800 | 12.70% |
Dec 31, 2011 | 6,300 | 3,872 | 159.47% |
May 31, 2010 | 2,428 | 59 | 2.49% |
May 31, 2009 | 2,369 | 1,214 | 105.11% |
Jan 1, 2008 | 1,155 | 241 | 26.37% |
Jan 1, 2007 | 914 | 528 | 136.79% |
Jan 1, 2006 | 386 | 38 | 10.92% |
Jan 31, 2005 | 348 | 18 | 5.45% |
Jan 31, 2004 | 330 | 26 | 8.55% |
Feb 28, 2003 | 304 | -62 | -16.94% |
Feb 28, 2002 | 366 | -125 | -25.46% |
Feb 28, 2001 | 491 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
MDRX News
- 5 days ago - MedEvolve Announces Strategic Marketing Relationship with Veradigm to Enhance Revenue Cycle Management Solutions for Healthcare Organizations - Business Wire
- 26 days ago - Veradigm Network Solution Practice Fusion EHR Receives Top Ambulatory Rankings - Business Wire
- 4 weeks ago - Veradigm and Vim to Improve Payer-Provider Collaboration - Business Wire
- 5 weeks ago - Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders Foundation - PRNewsWire
- 7 weeks ago - Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Business Wire
- 7 weeks ago - Veradigm Announces Initial Financial Guidance for Fiscal 2024 - Business Wire
- 2 months ago - Veradigm Completes Acquisition of ScienceIO - Business Wire
- 2 months ago - Veradigm to Participate in TD Cowen Annual Health Care Conference - Business Wire